Clinuvel Pharmaceuticals (ASX: CUV) – Clinuvel Refocuses Strategy on U.S. Markets
Clinuvel Pharmaceuticals has announced a strategic reorganisation effective 1 January 2027 that will relocate its corporate headquarters to the...
Clinuvel Pharmaceuticals has announced a strategic reorganisation effective 1 January 2027 that will relocate its corporate headquarters to the...
Frasers Group plc has extended its takeover offer for Accent Group Limited to 30 September 2026, pushing back the deadline by two months from the...
Frasers Group plc has extended its on-market takeover bid for Accent Group Limited to 30 September 2026, giving shareholders additional time to...
Santos Limited has demonstrated solid operational progress in its second quarter results, with major growth projects Barossa and Pikka now...
PolyNovo delivered revenue of AUD 150 million for FY26, representing 16.1% growth on the prior year and 20.3% in constant currency terms, with the...